Short Interest in Avanos Medical, Inc. (NYSE:AVNS) Rises By 11.3%

Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 614,500 shares, an increase of 11.3% from the November 15th total of 552,300 shares. Currently, 1.4% of the company's stock are sold short. Based on an average trading volume of 254,300 shares, the days-to-cover ratio is currently 2.4 days.

Avanos Medical Stock Performance

AVNS stock traded down $0.47 during mid-day trading on Friday, reaching $17.97. 421,445 shares of the stock traded hands, compared to its average volume of 245,104. The firm has a market capitalization of $825.90 million, a PE ratio of 52.85 and a beta of 0.95. The business has a 50-day moving average of $20.27 and a two-hundred day moving average of $21.44. Avanos Medical has a 52 week low of $17.39 and a 52 week high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Institutional Trading of Avanos Medical

Several hedge funds have recently added to or reduced their stakes in AVNS. Paradice Investment Management LLC lifted its stake in shares of Avanos Medical by 5.4% in the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company's stock valued at $26,791,000 after buying an additional 69,389 shares during the period. Geode Capital Management LLC raised its holdings in Avanos Medical by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company's stock valued at $25,337,000 after acquiring an additional 16,065 shares in the last quarter. Foundry Partners LLC lifted its position in shares of Avanos Medical by 1.1% in the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company's stock worth $3,918,000 after acquiring an additional 1,800 shares during the period. AQR Capital Management LLC grew its holdings in shares of Avanos Medical by 21.0% during the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company's stock worth $2,875,000 after purchasing an additional 25,467 shares in the last quarter. Finally, FMR LLC increased its position in shares of Avanos Medical by 34.6% during the third quarter. FMR LLC now owns 133,844 shares of the company's stock valued at $3,216,000 after purchasing an additional 34,421 shares during the period. Institutional investors own 95.17% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.